Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Poseida Therapeutics Inc (NQ: PSTX )

9.380 +6.520 (+227.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30,098,469
Open 9.280
Bid (Size) 9.320 (198)
Ask (Size) 9.360 (5)
Prev. Close 2.860
Today's Range 9.250 - 9.410
52wk Range 1.870 - 4.270
Shares Outstanding 86,916,199
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc.
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+177.51%
+177.51%
1 Month
+278.23%
+278.23%
3 Month
+206.54%
+206.54%
6 Month
+227.97%
+227.97%
1 Year
+243.59%
+243.59%

More News

Read More
Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Where Poseida Therapeutics Stands With Analysts
Via Benzinga
Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results
Via Benzinga
US Stocks Mixed; Best Buy Posts Downbeat Earnings
Via Benzinga
Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi LLP
Via Business Wire
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Via Benzinga
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
MaxCyte Appoints Cynthia Collins to its Board of Directors
From MaxCyte, Inc
Via GlobeNewswire
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.